CVS agrees to pay $315 million to settle federal opioid-dispensing case
CVS agrees to pay $315 million to settle a federal opioid-dispensing case, U.S. measles cases pass 4,000 as Pennsylvania reports another death, and the DEA moves to schedule concentrated kratom derivatives.
Former FDA medical officer urges withdrawal of Prader-Willi drug Vykat XR
A former FDA medical officer urges withdrawal of the Prader-Willi drug Vykat XR, the FDA approves pritelivir for refractory herpes, and peptide users report harms as an FDA panel backs wider compounding access.
FDA flags four deaths in Newron’s evenamide schizophrenia program
A Cochrane review links drug-company gifts and meals to less appropriate prescribing, the FDA flags four deaths in Newron’s evenamide program, and U.S. measles cases pass 4,000.